DanielCGrinnanMD
Pulmonology • Richmond, VACritical Care Medicine, Pleural Disease
Assistant Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Dr. Grinnan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1250 E Marshall Street
Internal Medicine Pulmonary
Richmond, VA 23298Phone+1 804-828-9071
Education & Training
University of Virginia Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
Duke University HospitalResidency, Internal Medicine, 2000 - 2003
Virginia Commonwealth University School of MedicineClass of 2000
Certifications & Licensure
VA State Medical License 2003 - 2026
NC State Medical License 2000 - 2004
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Pulmonary Hypertension Association Registry Start of enrollment: 2015 Oct 01
Roles: Principal Investigator, Contact, Study Chair
Publications & Presentations
PubMed
- Management and Outcomes of Kidney Transplant Candidates With Severe Pulmonary Hypertension: A Single-center Strategy and Experience.Dhiren Kumar, Nihar Raju, Bhupinder Prajapati, Irfan Moinuddin, Shreyank Tripathi
Transplantation Direct. 2024-06-01 - 17 citationsMinimal Clinically Important Difference in the 6-minute-walk Distance for Patients with Pulmonary Arterial Hypertension.Jude Moutchia, Robyn L McClelland, Nadine Al-Naamani, Dina H Appleby, Kristina Blank
American Journal of Respiratory and Critical Care Medicine. 2023-04-15 - 3 citationsSafety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design.Raymond L Benza, Veronica Franco, Mandar A Aras, Leslie Spikes, Daniel Grinnan
Respiratory Research. 2022-12-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
